- Title
- LBP-025 Once-monthly efimosfermin alfa in participants with metabolic dysfunction-associated steatohepatitis with F2/F3 fibrosis: post hoc results from a 24-week, randomized, double-blind, placebocontrolled, phase 2 trial
- Creators
- Rohit LoombaKris KowdleyMuhammad Y. SheikhNomita KimAnita KohliEric LawitzBrenda JeglinskiKelly KutchJose Manuel TrigoPatricia MendezMargaret KozielStuart KendrickSumanta MukherjeeMazen Noureddin
- Publication Details
- Journal of hepatology, Vol.84, pp.S78-S79
- Publisher
- Elsevier B.V
- Identifiers
- 991006287640402656
- Academic Unit
- Internal Medicine
- Language
- English
- Resource Type
- Journal article
Journal article
LBP-025 Once-monthly efimosfermin alfa in participants with metabolic dysfunction-associated steatohepatitis with F2/F3 fibrosis: post hoc results from a 24-week, randomized, double-blind, placebocontrolled, phase 2 trial
Journal of hepatology, Vol.84, pp.S78-S79
05/2026
Metrics
1 Record Views